OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SALEEM56

Salee Industry PCL

Commodity ChemicalsVerified

The company maintains a strong liquidity position, with a current ratio of 4.63, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to 122,583,270 THB, and free cash flow stands at 98,877,290 THB, supporting operational flexibility and potential reinvestment. The debt-to-equity ratio is 0.02, suggesting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 2.91% and a return on assets of 1.86%, which are below the industry median for Commodity Chemicals. The operating margin is 3.81% (calculated from operating income of 53,739,370 THB on revenue of 1,408,731,840 THB), indicating room for improvement in cost control and pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond Thailand. This concentration increases exposure to local economic and regulatory risks. Looking ahead, the company is projected to grow revenue by 12.3% in the current fiscal year and 8.1% in the next, based on analyst estimates and historical performance. However, the growth trajectory is contingent on stable raw material prices and demand in the domestic market. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares recently, and there is no indication of near-term dilution pressure. However, the low debt-to-equity ratio suggests limited capacity for aggressive capital expansion. Recent filings and transcripts indicate no material changes in the company's operations or strategic direction. The company continues to focus on cost optimization and market share retention in the domestic chemical sector.

30-day price · SALEEM(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySalee Industry PCL
TickerSALEEM.BK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Salee Industry PCL produces and distributes chemical products, primarily serving industrial and consumer markets in Thailand and the broader Southeast Asia region.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

The company maintains a strong liquidity position, with a current ratio of 4.63, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to 122,583,270 THB, and free cash flow stands at 98,877,290 THB, supporting operational flexibility and potential reinvestment. The debt-to-equity ratio is 0.02, suggesting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 2.91% and a return on assets of 1.86%, which are below the industry median for Commodity Chemicals. The operating margin is 3.81% (calculated from operating income of 53,739,370 THB on revenue of 1,408,731,840 THB), indicating room for improvement in cost control and pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond Thailand. This concentration increases exposure to local economic and regulatory risks. Looking ahead, the company is projected to grow revenue by 12.3% in the current fiscal year and 8.1% in the next, based on analyst estimates and historical performance. However, the growth trajectory is contingent on stable raw material prices and demand in the domestic market. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares recently, and there is no indication of near-term dilution pressure. However, the low debt-to-equity ratio suggests limited capacity for aggressive capital expansion. Recent filings and transcripts indicate no material changes in the company's operations or strategic direction. The company continues to focus on cost optimization and market share retention in the domestic chemical sector.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 4.63 and free cash flow of 98,877,290 THB.
  • Profitability metrics are below industry medians, with a return on equity of 2.91% and a return on assets of 1.86%.
  • Revenue is concentrated in a single business segment and geographic market, increasing exposure to local risks.
  • Analysts project revenue growth of 12.3% in the current fiscal year and 8.1% in the next, contingent on stable market conditions.
  • The company has no immediate liquidity or dilution risks, with a conservative capital structure and no recent share issuance.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$1.41B
Gross profit$316.1M
Operating income$53.7M
Net income$33.7M
R&D
SG&A
D&A
SBC
Operating cash flow$154.3M
CapEx-$50.0M
Free cash flow$98.9M
Total assets$1.81B
Total liabilities$649.5M
Total equity$1.16B
Cash & equivalents$122.6M
Long-term debt$18.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.16B
Net cash$104.1M
Current ratio4.6
Debt/Equity0.0
ROA1.9%
ROE2.9%
Cash conversion4.6%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSALEEMActivity
Op margin3.8%5.5% medp25 -0.0% · p75 10.8%below median
Net margin2.4%4.1% medp25 0.1% · p75 8.8%below median
Gross margin22.4%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.5%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity2.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Last actual EPS0.07 THB
Last actual revenue729,419,000 THB
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-24 14:27 UTC#00e2a875
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 07:23 UTCJob: a0a1ebb8